Cargando…
Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development
Vaccines have been developed under accelerated timelines to combat the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus. Although they are considered the best approach for preventing mortality, when assessing the safety of these vaccines, pregnant women have not been included in clinical trial...
Autores principales: | Karrow, Niel A., Shandilya, Umesh K., Pelech, Steven, Wagter-Lesperance, Lauraine, McLeod, Deanna, Bridle, Byram, Mallard, Bonnie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617890/ https://www.ncbi.nlm.nih.gov/pubmed/34835282 http://dx.doi.org/10.3390/vaccines9111351 |
Ejemplares similares
-
Correction: Karrow et al. Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development. Vaccines 2021, 9, 1351
por: Karrow, Niel A., et al.
Publicado: (2022) -
N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals
por: Tieu, Sophie, et al.
Publicado: (2023) -
Immunoceuticals: Harnessing Their Immunomodulatory Potential to Promote Health and Wellness
por: Tieu, Sophie, et al.
Publicado: (2022) -
Expression Profile of miRNA from High, Middle, and Low Stress-Responding Sheep during Bacterial Endotoxin Challenge
por: Shandilya, Umesh K., et al.
Publicado: (2023) -
Identification of Ovine Serum miRNAs Following Bacterial Lipopolysaccharide Challenge
por: Sharma, Ankita, et al.
Publicado: (2020)